ohpner Manages Elevator Advertising for Cancer Risk Test Service 'miSignal'
Key facts
- ohpner Manages Elevator Advertising for Cancer Risk Test Service 'miSignal'
- ohpner Inc., an offline marketing firm, has managed the placement of elevator advertisements for 'miSignal,' a urine-based cancer risk testing service operated by Craif Inc., with broadcasts starting May 25, 2026.
- Source: PR Times
- Date: May 27, 2026
Direct answer
ohpner Inc., an offline marketing firm, has managed the placement of elevator advertisements for 'miSignal,' a urine-based cancer risk testing service operated by Craif Inc., with broadcasts starting May 25, 2026.
- Citation
- ohpner Manages Elevator Advertising for Cancer Risk Test Service 'miSignal' (May 27, 2026), PR Times
- Source
- PR Times
- Date
- May 27, 2026
ohpner Inc., an offline marketing firm, has managed the placement of elevator advertisements for 'miSignal,' a urine-based cancer risk testing service operated by Craif Inc., with broadcasts starting May 25, 2026.
📋 Article Processing Timeline
- 📰 Published: May 27, 2026 at 13:20
- 🔍 Collected: May 31, 2026 at 23:14 (105h 54m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 23:25 (11 min after Collected)
ohpner Inc. (Shibuya-ku, Tokyo; CEO: Takeshi Doi), a provider of offline marketing services, has managed the placement of elevator advertisements for "miSignal," a service operated by Craif Inc. (Bunkyo-ku, Tokyo; CEO: Ryuichi Onose) that identifies the risk of 10 types of cancer through urine samples.
To expand the recognition of "miSignal," broadcasts began on elevator signage starting May 25, 2026. "miSignal" is a high-precision cancer risk test that can be performed at home, capable of detecting risks for 10 cancer types, including pancreatic cancer, from Stage 1.
ohpner provides comprehensive marketing solutions ranging from media selection for mobility ads, transportation ads, and other OOH media to creative production, ad distribution, and effectiveness measurement. The company continues to support client business growth through its expertise in offline advertising and marketing consulting.
To expand the recognition of "miSignal," broadcasts began on elevator signage starting May 25, 2026. "miSignal" is a high-precision cancer risk test that can be performed at home, capable of detecting risks for 10 cancer types, including pancreatic cancer, from Stage 1.
ohpner provides comprehensive marketing solutions ranging from media selection for mobility ads, transportation ads, and other OOH media to creative production, ad distribution, and effectiveness measurement. The company continues to support client business growth through its expertise in offline advertising and marketing consulting.
FAQ
ohpner株式会社は今回どのような役割を担いましたか？
Craif株式会社が運営する尿がん検査サービス「マイシグナル」のエレベーター広告掲載およびマーケティング支援を担当しました。
広告の放映はいつから開始されましたか？
2026年5月25日より、エレベーターサイネージにて放映が開始されました。
「マイシグナル」とはどのようなサービスですか？
自宅で尿を採取して送るだけで、すい臓がんを含む10種のがんリスクをステージ1から特定できる高精度な検査サービスです。
ohpner株式会社の主な事業内容は？
オフライン広告（モビリティ広告、交通広告、OOH等）のメディア選定、クリエイティブ制作、配信、効果測定、およびマーケティングコンサルティングです。
今回の広告掲載の目的は何ですか？
尿がん検査サービス「マイシグナル」の認知拡大を目的としています。